We’re integral in making clinical trials succeed by eliminating the human errors and inefficiencies that are often experienced in conducting clinical trials, which regularly yield to abandoned pharmaceutical pipelines.
With Elixia you can…
Combating COVID-19 with AstraZeneca
Elixia managed sites were responsible for representing the total of 47% of the enrolled minority population worldwide for Monoclonal Antibody therapy.
Extend access to advanced therapeutics throughout local communities
Elixia puts communities first through meaningful patient acquisition and education programs led by its Patient Outreach and Support Division.
Operations designed for rapid study start-up
Concerted operations across 5 Elixia divisions allow for study startup through study activation timelines to see record efficiencies.
Meet database locks sooner
Elixia has consistently led the global enrollment efforts for its last 25 trials conducted.
We’ve reinvented and refined the clinical trials management process
STUDY START-UP AND REGULATORY SUBMISSION
FIRST RANDOMIZED PATIENT POST SITE ACTIVATION
1 – 2 Days
INTERNALLY DIRECTED SITE AUDIT
Within 10 Days
50% OF INITIAL ENROLLMENT GOAL, ON AVERAGE
HOW WE DO IT —
Expedite trials with
the use of our advanced technology platform.
Rapid Patient Enrollment
Leverage the dashboard view to track network-wide study enrollment progress across each trial, in real-time.
Focus on Diversity and Inclusion
Enroll key populations for a comprehensive understanding of drug efficacy in real-world representative patient populations.
An extensive network across the nation supporting multiple areas of healthcare.
A network with 30+ years of experience specific to the Nephrology and Cardiology indications of clinical research.
The only clinical trials initiative focused on 100% inclusive behavioral health trials through a team of top Clinical Psychologists.
A rapid footprint on infectious disease trials, as seen by record-setting study startup and enrollment metrics throughout COVID-19.
Access top leaders across different sectors of healthcare to drive value in the clinical trials space and forge better patient outcomes
Interconectivity & Uniformity
High levels of operational consistency and access across sites help Elixia ensure expedition of startup processes and collaborative sharing of best practices across investigators and clinicians.
The convergence of medical and scientific expertise within the Elixia umbrella allows the site network to constantly drive more enterprise value with each trial, in a progressive and nimble manner.
Specialized in clinical trials development, management, execution, and analysis throughout Phase II-IV of drug development
Fast track your clinical trial today.
From trial recruitment to vital data platforms, we offer the most efficient, fastest-to-market solution.